Table 1.
MpMRI and bpMRI protocols.
| TR (ms) | TE (ms) | Fov (mm × mm) | Matrix | b values | NSA | Slice (mm) | Scan time (min:s) | Temp res (min:s) | |
|---|---|---|---|---|---|---|---|---|---|
| mpMRI∗ | |||||||||
| T2 sag | 3000 | 90 | 160 × 198 | 268 × 326 | 2 | 3 | 06:06 | ||
| T2 ax | 4000 | 90 | 180 × 180 | 400 × 400 | 1 | 3 | 09:19 | ||
| DWI ax | 13743 | 71 | 180 × 180 | 84 × 80 | 0; 100; 800; 2000 | 2 | 4 | 06:33 | |
| T2 cor | 3504 | 90 | 190 × 190 | 316 × 312 | 1 | 3 | 04:16 | ||
| DCE∗∗ | 10 | 5 | 180 × 158 | 256 × 221 | 1 | 5 | 03:03 | 00:15 | |
| bpMRI | |||||||||
| T2 sag (scout) | 3 | 1·65 | 270 × 270 | 180 × 180 | 2 | 3 | 00:29 | ||
| T2 ax | 3475 | 90 | 180 × 180 | 400 × 400 | 1 | 3 | 08:14 | ||
| DWI ax | 10000 | 71 | 180 × 180 | 84 × 80 | 0; 100; 800; 2000 | 2 | 4 | 06:30 | |
Abbreviations: mpMRI, multiparametric magnetic resonance imaging; bp, biparametric (MRI); TR, repetition time; TE, echo time; Fov, field of view; NSA, number of signal averages; Temp res, temporal resolution; sag, sagittal; ax, axial; DWI, diffusion-weighted images; cor, coronal; DCE, dynamic contrast-enhanced; ms, milliseconds.
∗
Administered if tolerated (1 mL hyoscine butylbromid [20 mg/mL Buscopan injection fluid; Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany] and 1 mL glucagon [1 mg/mL GlucaGen; Novo Nordisk A/S, Bagsværd, Denmark]).
∗∗
Administered 0·2 mL/kg gadoteric acid [15–20 mL 279·3 mg/mL Dotarem injection fluid; Guerbet B. P., Villepinte, France].